Latest News and Press Releases
Want to stay updated on the latest news?
- 
                            
Certara today announced the launch of Certara IQ, a scalable, AI-powered Quantitative Systems Pharmacology (QSP) solution.
 - 
                            
Certara today announced that the European Medicines Agency has formally qualified the Simcyp® Simulator for use in regulatory submissions across the EU.
 - 
                            
Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing
 - 
                            
Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities
 - 
                            
CERTARA APPOINTS DR. ADRIAN MCKEMEY AS PRESIDENT OF DRUG DEVELOPMENT SOLUTIONS
 - 
                            
Dublin, Jan. 24, 2025 (GLOBE NEWSWIRE) -- The "Biosimulation Market Report 2025" has been added to ResearchAndMarkets.com's offering.The biosimulation market size is forecast to see rapid growth in...
 - 
                            
Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Biosimulation Market (2024 Edition): Analysis By Type (Services, Software), By Application, By Deployment Model Outlook, By Region, By Country: Market...
 - 
                            
Dublin, Dec. 12, 2024 (GLOBE NEWSWIRE) -- The "Biosimulation Market Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.The biosimulation market is projected to reach USD...
 - 
                            
RADNOR, Pa., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today showcases its impact on research by celebrating more than 100...
 - 
                            
Certara today announced the appointment of John Reynders, PhD to its Board of Directors, effective October 15, 2024.